Congenital 21-hydroxylase deficiency as a new deletion mutation. Detection in a proband during subsequent prenatal diagnosis by HLA typing and DNA analysis.
A child with 21-OH-def whose 9 weeks' pregnant mother was referred for prenatal diagnosis was found upon very careful histocompatibility testing to lack expression of any of his father's HLA antigens on his peripheral blood lymphocytes. The possibility of alternative paternity was considered to be extremely unlikely after additional genetic marker tests. The conclusion that the affected child's disease resulted from inheritance of a maternal CYP21B (21-OH) deletion and a de novo deletion in the paternal chromosome 6 segment that includes both the CYP21B (21-OH) and HLA genes was confirmed by subsequent DNA analysis using 21-OH, C4, DPB, and PCH6 probes. The presence of a heterozygous RFLP for DPB, the absence of a deletion for either CYP21B (21-OH) or C4 genes, and the presence of a paternal HLA antigen haplotype on the fetal cells additionally indicated that the fetus lacked the same deletion and could be predicted to be completely normal.
Hejtmancik
J F
JF
Baylor College of Medicine, Houston, Texas.
Black
S
S
Harris
S
S
Ward
P A
PA
Callaway
C
C
Ledbetter
D
D
Morris
J
J
Leech
S H
SH
Pollack
M S
MS
D000312:Adrenal Hyperplasia, Congenital; D002648:Child; D002871:Chromosome Banding; D002896:Chromosomes, Human, Pair 6; D004252:DNA Mutational Analysis; D005260:Female; D017353:Gene Deletion; D005819:Genetic Markers; D006680:HLA Antigens / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013255:Steroid 21-Hydroxylase / Q000235:genetics*
D005819:Genetic Markers; D006680:HLA Antigens; D013255:Steroid 21-Hydroxylase